Detection and Delineation of Oral Cancer With a PARP1-Targeted Optical Imaging Agent
More sensitive and specific methods for early detection are imperative to improve survival rates in oral cancer. However, oral cancer detection is still largely based on visual examination and histopathology of biopsy material, offering no molecular selectivity or spatial resolution. Intuitively, th...
Saved in:
Main Authors: | Susanne Kossatz, Wolfgang Weber, Thomas Reiner |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-08-01
|
Series: | Molecular Imaging |
Online Access: | https://doi.org/10.1177/1536012117723786 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current Practice and Emerging Molecular Imaging Technologies in Oral Cancer Screening
by: Arianna Strome BS, et al.
Published: (2018-11-01) -
Recurrent Cervical Cancer Treated Successfully with Single-Agent PARP-Inhibitor, Olaparib
by: Maya Gross, et al.
Published: (2022-01-01) -
PARP Inhibitors in the Treatment of Ovarian Cancer
by: Andrzej Paweł Zuzak, et al.
Published: (2025-02-01) -
Optical Coherence Tomography (OCT) in oral cancer: A promising imaging modality for early detection and monitoring
by: P. Kowsalya, et al.
Published: (2024-06-01) -
Editorial: Ovarian cancer targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more, volume II
by: Zhi-Bin Wang, et al.
Published: (2025-02-01)